Daniel Albert, MD: Telemedicine for Rheumatic Care

Video

How rheumatologists use telemedicine during COVID-19.

Telemedicine has been a boutique enterprise for the last dozen years, but recently, due to the coronavirus disease 2019 (COVID-19) pandemic, it has become front and center for many practitioners, including those focused on rheumatic care.

Daniel Albert, MD, of Dartmouth-Hitchcock, told HCPLive® in a recent interview that many providers and patients have had to do a quick ramp-up for the tools necessary to conduct such care and be cared for in such a way.

“It seems like it’s been very appealing to both groups and hopefully it will continue in largely the current format rather than the one that was unfortunately highly, highly regulated with a lot of barriers before COVID,” Albert said.

For Albert, he has an electronic health record (EHR) with a variant for his institution which permits a great deal of flexibility in terms of communication between patients and providers. The EHR allows for written documents, videos, still photos, and verbal and written interchange.

The platform that allows Albert to have a seamless video interaction with patients is called Vidyo. There are other variants that may have improved video or audio. A newer variant could allow for more devices being connected to the same interphase, and on Albert’s end, other students and staff members can be a part of the call to facilitate the conduct of the counter.

Providers are being careful to stay away from non-HIPAA compliant platforms like FaceTime and Skype.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.